全文获取类型
收费全文 | 37980篇 |
免费 | 2901篇 |
国内免费 | 121篇 |
专业分类
耳鼻咽喉 | 365篇 |
儿科学 | 1038篇 |
妇产科学 | 691篇 |
基础医学 | 5486篇 |
口腔科学 | 648篇 |
临床医学 | 3983篇 |
内科学 | 8135篇 |
皮肤病学 | 777篇 |
神经病学 | 3896篇 |
特种医学 | 1390篇 |
外国民族医学 | 11篇 |
外科学 | 5266篇 |
综合类 | 437篇 |
一般理论 | 30篇 |
预防医学 | 3107篇 |
眼科学 | 729篇 |
药学 | 2652篇 |
中国医学 | 93篇 |
肿瘤学 | 2268篇 |
出版年
2023年 | 311篇 |
2022年 | 501篇 |
2021年 | 975篇 |
2020年 | 675篇 |
2019年 | 900篇 |
2018年 | 1073篇 |
2017年 | 860篇 |
2016年 | 967篇 |
2015年 | 1018篇 |
2014年 | 1390篇 |
2013年 | 1717篇 |
2012年 | 2696篇 |
2011年 | 2806篇 |
2010年 | 1590篇 |
2009年 | 1315篇 |
2008年 | 2147篇 |
2007年 | 2298篇 |
2006年 | 2192篇 |
2005年 | 1983篇 |
2004年 | 1879篇 |
2003年 | 1577篇 |
2002年 | 1477篇 |
2001年 | 616篇 |
2000年 | 627篇 |
1999年 | 562篇 |
1998年 | 341篇 |
1997年 | 258篇 |
1996年 | 258篇 |
1995年 | 227篇 |
1994年 | 194篇 |
1993年 | 149篇 |
1992年 | 324篇 |
1991年 | 301篇 |
1990年 | 309篇 |
1989年 | 249篇 |
1988年 | 252篇 |
1987年 | 274篇 |
1986年 | 288篇 |
1985年 | 272篇 |
1984年 | 226篇 |
1983年 | 178篇 |
1982年 | 125篇 |
1979年 | 240篇 |
1978年 | 161篇 |
1977年 | 140篇 |
1975年 | 122篇 |
1974年 | 131篇 |
1973年 | 138篇 |
1972年 | 123篇 |
1971年 | 122篇 |
排序方式: 共有10000条查询结果,搜索用时 18 毫秒
951.
OBJECTIVE: Noninvasive blood pressure (BP) measurement is dependent on either auscultation or oscillometry. The Tensoval duo control device uses auscultatory and/or oscillometric technology to determine BP. We evaluated the accuracy of this device in adults according to the British Hypertension Society (BHS) protocol and the International Protocol of the European Hypertension Society. METHODS: Ethical approval was obtained and participants gave written informed consent. Eighty-five participants who fulfilled the protocol criteria were recruited. Nine sequential same arm measurements were taken from each participant by two trained observers, comparing the device to mercury sphygmomanometery. Data analysis was performed according to the respective protocol guidelines. RESULTS: The device achieved an A grade for both systolic and diastolic pressures with 68, 91 and 98% of systolic and 73, 91 and 98% of diastolic differences within the 相似文献
952.
Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors 总被引:2,自引:0,他引:2
Wild A Ramaswamy A Langer P Celik I Fendrich V Chaloupka B Simon B Bartsch DK 《The Journal of clinical endocrinology and metabolism》2003,88(3):1367-1373
Molecular mechanisms contributing to the tumorigenesis of pancreatic endocrine tumors (PETs) are still not well understood. Allelic deletions at chromosome 22q12.3 were detected in about 30-60% of PETs, suggesting that inactivation of one or more tumor suppressor genes on this chromosomal arm is important for their pathogenesis. Because the putative tumor suppressor gene tissue inhibitor of metalloproteinase-3 (TIMP-3) has been located at 22q12.3, we undertook a genetic analysis of TIMP-3 to determine its role in the tumorigenesis of PETs. Single-strand conformational polymorphism analysis, methylation-specific PCR, RNA expression analysis, and immunohistochemistry of TIMP-3 were performed in 21 sporadic PETs. Thirteen of 21 PETs (62%) revealed TIMP-3 alterations, including promoter hypermethylation and homozygous deletion. The predominant TIMP-3 alteration was promoter hypermethylation, identified in 8 of 18 (44%) PETs. It was tumor-specific and corresponded to loss or strong reduction of TIMP-3 protein expression. Notably, 11 of 14 (79%) PETs with metastases had TIMP-3 alterations, compared with only 1 of 7 (14%) PETs without metastases (P < 0.02). These data suggest a possibly important role of TIMP-3 in the tumorigenesis of human PETs, especially in the development of metastases, which has to be further evaluated in large-scale studies. 相似文献
953.
Stenzel-Poore MP Stevens SL Xiong Z Lessov NS Harrington CA Mori M Meller R Rosenzweig HL Tobar E Shaw TE Chu X Simon RP 《Lancet》2003,362(9389):1028-1037
954.
Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls 总被引:7,自引:0,他引:7
BACKGROUND: Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene-many of which cause cystic fibrosis-have also been reported in patients with chronic pancreatitis. The authors examine whether mild or severe CFTR mutations, homozygous or compound heterozygous CFTR mutations, or even simple cystic fibrosis carrier status alone increases the risk of developing pancreatitis. METHODS: After exclusion of patients with trypsinogen (PRSS1) mutations, cystic fibrosis, or pulmonary disease, and with known risk factors for pancreatitis 67 patients with idiopathic chronic pancreatitis (ICP) from northwest Germany and 60 geographically and ethnically matched controls were recruited. The entire coding region of the CFTR gene was sequenced in all patients and controls. ICP patients were also analysed for serine protease inhibitor Kazal type 1 (SPINK1) gene mutations. RESULTS: Abnormal CFTR alleles were found to be twice as frequent in ICP patients as in controls (25/134 v 11/120; p<0.05). Three of four severe CFTR mutations detected in patients were compound heterozygous with another abnormal CFTR allele, whereas among controls three severe CFTR mutations were found in heterozygous cystic fibrosis carriers. In ICP patients 19 uncommon/mild mutations, including combinations of the 5T allele with 12TG repeats, were identified compared with only five in controls (p = 0.012). Heterozygous SPINK1 mutations were detected in eight ICP patients (15% v 1% in controls) but only one also carried an additional mild CFTR mutation. CONCLUSIONS: These data show that not only compound heterozygosity, but also cystic fibrosis carrier status for different types of CFTR mutations, including uncommon/mild mutations, significantly increase the risk of developing pancreatitis. Although 45% of the study's ICP patients carried predisposing genetic risk factors (for example, mutations in CFTR or SPINK1), the authors found no evidence that the risk conveyed by CFTR mutations depends on co-inherited SPINK1 mutations. 相似文献
955.
Laurence P. Diggs Benjamin Ruf Chi Ma Bernd Heinrich Linda Cui Qianfei Zhang John C. McVey Simon Wabitsch Sophia Heinrich Umberto Rosato Walter Lai Varun Subramanyam Thomas Longerich Sven H. Loosen Tom Luedde Ulf Peter Neumann Sabina Desar David Kleiner Tim F. Greten 《Journal of hepatology》2021,74(5):1145-1154
- Download : Download high-res image (164KB)
- Download : Download full-size image
956.
Chih-Hung Guo Simon Hsia Min-Yi Shih Fang-Chin Hsieh Pei-Chung Chen 《International journal of medical sciences》2015,12(9):748-758
Recent evidence suggests that selenium (Se) yeast may exhibit potential anti-cancer properties; whereas the precise mechanisms remain unknown. The present study was aimed at evaluating the effects of Se yeast on oxidative stress, growth inhibition, and apoptosis in human breast cancer cells. Treatments of ER-positive MCF-7 and triple-negative MDA-MB-231 cells with Se yeast (100, 750, and 1500 ng Se/mL), methylseleninic acid (MSA, 1500 ng Se/mL), or methylselenocysteine (MSC, 1500 ng Se/mL) at a time course experiment (at 24, 48, 72, and 96 h) were analyzed. Se yeast inhibited the growth of these cancer cells in a dose- and time-dependent manner. Compared with the same level of MSA, cancer cells exposure to Se yeast exhibited a lower growth-inhibitory response. The latter has also lower superoxide production and reduced antioxidant enzyme activities. Furthermore, MSA (1500 ng Se/mL)-exposed non-tumorigenic human mammary epithelial cells (HMEC) have a significant growth inhibitory effect, but not Se yeast and MSC. Compared with MSA, Se yeast resulted in a greater increase in the early apoptosis in MCF-7 cells as well as a lower proportion of early and late apoptosis in MDA-MB-231 cells. In addition, nuclear morphological changes and loss of mitochondrial membrane potential were observed. In conclusion, a dose of 100 to 1500 ng Se/mL of Se yeast can increase oxidative stress, and stimulate growth inhibitory effects and apoptosis induction in breast cancer cell lines, but does not affect non-tumorigenic cells. 相似文献
957.
958.
959.
960.
Severe congenital neutropenia with neurological impairment due to a homozygous VPS45 p.E238K mutation: A case report suggesting a genotype–phenotype correlation
下载免费PDF全文
![点击此处可从《American journal of medical genetics. Part A》网站下载免费的PDF全文](/ch/ext_images/free.gif)